0001127602-20-028214.txt : 20201105 0001127602-20-028214.hdr.sgml : 20201105 20201105114619 ACCESSION NUMBER: 0001127602-20-028214 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20200617 FILED AS OF DATE: 20201105 DATE AS OF CHANGE: 20201105 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: LaPlume Joseph W CENTRAL INDEX KEY: 0001767215 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-15943 FILM NUMBER: 201289394 MAIL ADDRESS: STREET 1: 251 BALLARDVALE STREET CITY: WILMINGTON STATE: MA ZIP: 01887 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: CHARLES RIVER LABORATORIES INTERNATIONAL, INC. CENTRAL INDEX KEY: 0001100682 STANDARD INDUSTRIAL CLASSIFICATION: SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH [8731] IRS NUMBER: 061397316 FISCAL YEAR END: 1226 BUSINESS ADDRESS: STREET 1: 251 BALLARDVALE ST CITY: WILMINGTON STATE: MA ZIP: 01887 BUSINESS PHONE: 781-222-6000 MAIL ADDRESS: STREET 1: 251 BALLARDVALE ST CITY: WILMINGTON STATE: MA ZIP: 01887 FORMER COMPANY: FORMER CONFORMED NAME: CHARLES RIVER LABORATORIES INTERNATIONAL INC DATE OF NAME CHANGE: 20000605 FORMER COMPANY: FORMER CONFORMED NAME: CHARLES RIVER LABORATORIES HOLDINGS INC DATE OF NAME CHANGE: 19991208 4 1 form4.xml PRIMARY DOCUMENT X0306 4 2020-06-17 0001100682 CHARLES RIVER LABORATORIES INTERNATIONAL, INC. CRL 0001767215 LaPlume Joseph W 251 BALLARDVALE STREET WILMINGTON MA 01887 1 EVP, Corp Strategy & Develop Common Stock 2020-06-17 5 G 0 E 285 0 D 11356 D Common Stock 2020-11-04 4 M 0 492 88.05 A 11848 D Common Stock 2020-11-04 4 M 0 3205 109.34 A 15053 D Common Stock 2020-11-04 4 M 0 3042 144.67 A 18095 D Common Stock 2020-11-04 4 S 0 2639 249.0907 D 15456 D Common Stock 2020-11-04 4 S 0 580 250.229 D 14876 D Common Stock 2020-11-04 4 S 0 3520 251.1773 D 11356 D Stock Options (Right to Buy) 88.05 2020-11-04 4 M 0 492 0 D 2018-02-24 2022-02-24 Common Stock 492 3493 D Stock Options (Right to Buy) 109.34 2020-11-04 4 M 0 3205 0 D 2019-02-23 2023-02-23 Common Stock 3205 6409 D Stock Options (Right to Buy) 144.67 2020-11-04 4 M 0 3042 0 D 2020-02-22 2024-02-22 Common Stock 3042 9128 D This transaction was executed in multiple trades at prices ranging from $248.83 to $249.28. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. This transaction was executed in multiple trades at prices ranging from $250.04 to $250.64. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. This transaction was executed in multiple trades at prices ranging from $250.91 to $251.25. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. /s/ Joseph W. LaPlume 2020-11-05